 | This articlerelies largely or entirely on asingle source. Relevant discussion may be found on thetalk page. Please helpimprove this article byintroducing citations to additional sources. Find sources: "3-Methoxy-4-ethoxyphenethylamine" – news ·newspapers ·books ·scholar ·JSTOR(November 2022) |
 | |
| Clinical data | |
|---|---|
| Other names | MEPEA |
| Routes of administration | Oral[1] |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | Unknown[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.199.597 |
| Chemical and physical data | |
| Formula | C11H17NO2 |
| Molar mass | 195.262 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
3-Methoxy-4-ethoxyphenethylamine (MEPEA) is a lesser-knowndrug.[1] It was first synthesized byAlexander Shulgin.[1] In his bookPiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 300 mg, and theduration unknown.[1] MEPEA is said to produce a light lifting feeling and a +1 on theShulgin Rating Scale.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of MEPEA.[1]
 | Thispsychoactive drug-related article is astub. You can help Wikipedia byexpanding it. |